Skip to main content
Q-Linea logo

Q-Linea — Investor Relations & Filings

Ticker · QLINEA ISIN · SE0011527845 LEI · 549300BXVB4XRM8WSC73 ST Manufacturing
Open in API
Filings indexed 326 across all filing types
Latest filing 2026-05-29 Board/Management Inform…
Country SE Sweden
Listing ST QLINEA

About Q-Linea

https://www.qlinea.com/

Q-Linea is an infection diagnostics company that develops and manufactures solutions for infectious diseases, with a primary focus on sepsis. The company's core product is the ASTar instrument, a fully automated, benchtop system that provides rapid phenotypic antimicrobial susceptibility testing (AST) directly from positive blood cultures. The ASTar system is designed to significantly reduce the time to result compared to traditional diagnostic methods, which can take up to 48 hours. By delivering faster results, the technology enables clinicians to make earlier, more informed decisions on appropriate antibiotic treatments for critically ill patients. This capability aims to improve patient outcomes, support antibiotic stewardship, and help combat the development of antimicrobial resistance.

Recent filings

Filing Released Lang Actions
Annika Blondeau Henriksson new interim CFO
Board/Management Information Classification · 15% confidence The document is a company announcement stating the appointment of a new interim CFO and IR, describing a management change and succession details. This clearly falls under Board/Management Information rather than a formal financial report or filing related to financial performance.
2026-05-29 English
Annika Bloendeau Henriksson ny interim CFO
Board/Management Information Classification · 86% confidence The text is a straightforward announcement of a change in senior management – the appointment of an interim CFO – without any financial statements or broader report content. This matches the definition of Board/Management Information (MANG).
2026-05-29 Swedish
KOMMUNIKÉ FRÅN ÅRSSTÄMMA I Q-LINEA AB (PUBL)
Declaration of Voting Results & Voting Rights Announcements Classification · 85% confidence The document is a post-AGM communique summarizing the resolutions passed at the Annual General Meeting, including approvals of financial statements, discharge of liability, board elections, remuneration decisions, incentive programs, and authorizations for share buybacks and issues. It reports the voting outcomes of shareholder decisions rather than containing the full annual report or financial statements. This aligns with “Declaration of Voting Results & Voting Rights Announcements” (DVA).
2026-05-27 Swedish
BULLETIN FROM ANNUAL GENERAL MEETING IN Q-LINEA AB (PUBL)
Declaration of Voting Results & Voting Rights Announcements Classification · 93% confidence The document is a bulletin summarizing the resolutions passed at the Annual General Meeting, including votes on financial statements, board elections, remuneration, share authorizations, etc. It is not the full annual report nor a presentation deck, but rather the official voting outcomes and resolutions from the AGM. This fits the definition of a Declaration of Voting Results & Voting Rights Announcement (DVA).
2026-05-27 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Delårsrapport 1 januari – 31 mars 2026' which translates to 'Interim Report January 1 – March 31, 2026'. It contains detailed financial data for the first quarter of 2026, including revenue, EBIT, net income, cash flow, and key performance indicators. It also discusses significant events during and after the quarter, commercial developments, FDA approvals, and strategic outlook. The length is about 15,000 characters, indicating a comprehensive report rather than a brief announcement. The content includes actual financial statements and substantive analysis for a period shorter than a full fiscal year (quarterly). Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2026
2026-04-30 English
Interim / Quarterly Report 2026
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Interim report 1 January – 31 March 2026' and contains detailed financial data for the first quarter of 2026, including net sales, operating results, profit after tax, earnings per share, cash flow, and equity. It also discusses significant events during and after the quarter, operational updates, commercial progress, and strategic outlook. The length of the document is substantial (15,000 characters), and it includes comprehensive financial statements and analysis for a period shorter than a full fiscal year (quarterly). This matches the definition of an Interim / Quarterly Report (IR). There is no indication that this is merely an announcement or a certification, and the content is substantive and detailed, not just a summary or presentation. Therefore, the correct classification is IR with high confidence. Q1 2026
2026-04-30 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.